Biotech · Private company
SOFIE
Track this companyFree. Adds SOFIE to your Dealase workspace and tells you when its record changes.
Clinical trials53 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- [18F]FAPI-74 PET/CTPhase 3 · Esophageal CancerClinicalTrials.gov · fetched Nov 12, 2026
- [18F]FAPI-74 PET/CTPhase 3 · Pancreatic Ductal Adenocarcinoma (PDAC)ClinicalTrials.gov · fetched Nov 12, 2026
- [18F]FAPI-74 PET/CTPhase 2 · Gastrointestinal CancersClinicalTrials.gov · fetched Nov 12, 2026
- [68Ga]FAPI-46Phase 2 · PDAC - Pancreatic Ductal AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsRECRUITING · started Mar 12, 2026ClinicalTrials.gov NCT07077213 · fetched Nov 12, 2026
- Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)PHASE3 · RECRUITING · started Dec 11, 2025ClinicalTrials.gov NCT07217717 · fetched Nov 12, 2026
- Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.PHASE3 · RECRUITING · started Nov 14, 2025ClinicalTrials.gov NCT07217704 · fetched Nov 12, 2026
- Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersPHASE2 · COMPLETED · started Apr 28, 2023ClinicalTrials.gov NCT05641896 · fetched Nov 12, 2026
- Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal CarcinomaPHASE2 · COMPLETED · started May 2, 2022ClinicalTrials.gov NCT05262855 · fetched Nov 12, 2026